stockmarketproxy
/
VTRSNasdaq SEC EDGAR

Viatris Inc

Pharmaceutical Preparations·CANONSBURG, PA·FY end 12/31·CIK 1792044
OverviewFinancialsCompensationGovernanceInsidersFilings

Board of Directors

13 members · 12 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
W. Don CornwellDirector5y78AuditRiskGovernance and Sustainability
Frank D'AmelioDirector0y68CompFinance
JoEllen Lyons DillonDirector5y62AuditCompExecutiveGovernance and Sustainability
Elisha FinneyDirector3y64AuditFinance
Leo GroothuisDirector2y53RiskExecutiveGovernance and Sustainability
Melina HigginsChair5y58ExecutiveFinance
James M. KiltsDirector5y78CompFinance
Richard MarkDirector5y72AuditRiskExecutiveFinance
Mark ParrishDirector5y70RiskExecutiveGovernance and SustainabilityTech
Michael Severino, M.D.Director0y60AuditTech
David SimmonsDirector0y61CompTech
Scott A. SmithCEO and Director3y63Tech
Rogério Vivaldi Coelho, M.D.Director1y62RiskTech

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.